Towards Healthcare
Cancer Vaccines Market
Updated Date: 01 November 2025   |   Report Code: 5153
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Cancer Vaccines Market Opportunities, Challenges and Breakthroughs to Watch

According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous efforts taken by governments and key stakeholders drive the market's growth.

Last Updated : 01 November 2025 Category: Therapeutic Area Insight Code: 5153 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
      Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Europe Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Asia-Pacific Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Latin America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Company Profiles

  • Generex Biotechnology Corporation
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Immunocellular Therapeutics, Ltd
  • Vaccinogen, Inc.
  • GlaxoSmithKline plc (GSK)
  • Advaxis Inc.
  • Dynavax Technologies Corporation
  • Merck & Co., Inc.
  • SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION)
  • UbiVac
  • Amgen Inc.

Conclusion & Recommendations

FAQ's

Answer : Yes. Vaccines used for treatment are called immunotherapy, treatment vaccines, or therapeutic vaccines. These vaccines prevent the reoccurrence of cancer and the destruction of cancer cells post-treatment, as well as prevent cancer from spreading.

Answer : Lung cancer, lymphoma, prostate cancer, ovarian cancer, melanoma, breast cancer, mesothelioma, cervical cancer and reproductive organ cancer.

Answer : World Health Organization, National Cancer Institute, National Library of Medicine, Press Information Bureau and Cancer Research Institute.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar